Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2015 08:45 ET | Source: Collegium Pharmaceutical

Collegium Announces FDA Advisory Committee Meeting for Xtampza(TM) ER, an Abuse-Deterrent Analgesic for Chronic Pain

CANTON, Mass., Aug. 7, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and...
July 06, 2015 16:15 ET | Source: Collegium Pharmaceutical

Collegium Added to Russell 2000(R), 3000(R) and Global Indexes

CANTON, Mass., July 6, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced that it has been added to the Russell 2000®, Russell 3000®, and Russell Global Indexes...
July 01, 2015 08:30 ET | Source: Collegium Pharmaceutical

Collegium Expands Leadership Team With Vice President of Regulatory Affairs and Quality Assurance

CANTON, Mass., July 1, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that John (Jack) Weet, Ph.D., has joined the company as its Vice President of Regulatory...
June 25, 2015 08:15 ET | Source: Collegium Pharmaceutical

Collegium Announces Publication of "Comparing the Effect of Tampering on the Oral Pharmacokinetic Profiles of Two Extended-Release Oxycodone Formulations With Abuse-Deterrent Properties," in Pain Medicine

CANTON, Mass., June 25, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the publication of a comparative clinical trial titled "Comparing the Effect of Tampering...
June 15, 2015 08:15 ET | Source: Collegium Pharmaceutical

Collegium to Present Xtampza ER(TM) Oral Human Abuse Potential Data at the College on Problems of Drug Dependence 77th Annual Meeting

CANTON, Mass., June 15, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the presentation of a scientific poster at the College on Problems of Drug Dependence 77th...
June 08, 2015 08:00 ET | Source: Collegium Pharmaceutical

Collegium Announces Issuance of U.S. Patent Covering DETERx(R) - an Abuse-Deterrent, Extended-Release Technology Platform

CANTON, Mass., June 8, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that U.S. Patent No. 9,044,398 was issued by the U.S. Patent and Trademark Office (USPTO)...
June 01, 2015 06:30 ET | Source: Collegium Pharmaceutical

Collegium Expands Commercial Organization With Key Appointments

CANTON, Mass., June 1, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the addition of Barry Duke as Executive Vice President and Chief Commercial Officer. In...
May 27, 2015 07:12 ET | Source: Collegium Pharmaceutical

Collegium to Present at the Jefferies 2015 Global Healthcare Conference

CANTON, Mass., May 27, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company's Chairman and CEO, Michael Heffernan, will present at the Jefferies 2015...
May 12, 2015 16:05 ET | Source: Collegium Pharmaceutical

Collegium Pharmaceutical Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares

CANTON, Mass., May 12, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today the closing of its initial public offering of 6,670,000 shares of its common stock at a...
May 07, 2015 07:45 ET | Source: Collegium Pharmaceutical

Collegium Pharmaceutical Announces Pricing of Its Initial Public Offering

CANTON, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc., (Nasdaq:COLL) today announced the pricing of its initial public offering of 5,800,000 shares of its common stock at a...